Perkins Capital Management’s AngioDynamics ANGO Stock Holding History

Perkins Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-45,750	Closed	-$1.05M	–	111
2019 Q1	$1.05M	Buy	45,750 +7,300	+19%	+$158K	0.69%	45
2018 Q4	$774K	Hold	38,450	–	–	0.6%	57
2018 Q3	$836K	Buy	38,450 +500	+1%	+$11.1K	0.5%	64
2018 Q2	$844K	Buy	+37,950	New	+$776K	0.6%	55
2018 Q1	–	Sell	-46,850	Closed	-$779K	–	119
2017 Q4	$779K	Sell	46,850 -1,800	-4%	-$30.7K	0.75%	48
2017 Q3	$831K	Sell	48,650 -1,000	-2%	-$16.8K	0.87%	39
2017 Q2	$805K	Sell	49,650 -5,200	-9%	-$82.2K	0.89%	40
2017 Q1	$952K	Buy	54,850 +3,000	+6%	+$50.2K	0.98%	32
2016 Q4	$875K	Hold	51,850	–	–	0.96%	37
2016 Q3	$909K	Buy	51,850 +7,000	+16%	+$114K	0.91%	40
2016 Q2	$644K	Buy	+44,850	New	+$560K	0.74%	48

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

TCM

Tributary Capital Management Omaha, Nebraska $1.22B AUM 44.12% 1-Year Est. Return

Perkins Capital Management's ANGO Position: Q2 2019 in Review

Perkins Capital Management sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 45,750 shares — an estimated $1.05M sold.

Perkins Capital Management first reported a position in ANGO in Q2 2016 and held it in 11 quarters. The position peaked at $1.05M in Q1 2019. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.

Perkins Capital Management reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
Perkins Capital Management sold 45,750 AngioDynamics shares in Q2 2019, an estimated $1.05M.
Perkins Capital Management first reported a position in AngioDynamics in Q2 2016 and held it in 11 quarters.
Perkins Capital Management's AngioDynamics position peaked at $1.05M in Q1 2019.
167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.

Based on Perkins Capital Management's 13F filing for Q2 2019, filed 9 Aug 2019.